CNS Drugs 2009;
نویسندگان
چکیده
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 139 1. Overview of Eating Disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 140 2. Rationale for Using Antiepileptic Drugs (AEDs) in Eating Disorders. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 142 3. First-Generation AEDs in the Treatment of Eating Disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 143 3.1 Phenytoin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 143 3.2 Carbamazepine. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 144 3.3 Valproate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 145 3.4 Other Agents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 145 4. Second-Generation AEDs in the Treatment of Eating Disorders. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 145 4.1 Topiramate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 145 4.2 Zonisamide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 148 4.3 Other Agents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 149 5. Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 149 Abstract Growing evidence suggests that antiepileptic drugs (AEDs) may beGrowing evidence suggests that antiepileptic drugs (AEDs) may be useful in managing some eating disorders. In the present paper, we provide a brief overview of eating disorders, the rationale for using AEDs in the treatment of these disorders and review the data supporting the effectiveness of specific AEDs in the treatment of patients with eating disorders. In addition, the potential mechanisms of action of AEDs in these conditions are
منابع مشابه
Ethanol Concentration and Its Correlation with CNS Suppressor Drugs in Postmortem Subjects
Background: Many studies have been done in order to interpret correctly the results of ethanol analysis and its related problems. Unfortunately, it was not easy to determine BAC rate, due to postmortem different conditions or personal and clinical differences in metabolism and excretion of ethanol. The time between death and autopsy, the environmental conditions (temperature and humidity) are i...
متن کاملMultifunctional drugs: a novel concept for psychopharmacology.
Beginning this month and appearing periodically in future columns, "Trends in Psychopharmacology" will cover a new concept and hot topic in the field, namely, that of "multifunctional drugs." The concept is presented in overview here. Future installments will cover specific drugs in greater depth. Multifunctional drugs include those agents with more than one putative therapeutic mechanism of ac...
متن کاملCNS Drugs 2009;
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 837 1. Early Stages of Schizophrenia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 839 2. Efficacy of Antipsychotic Drugs in First-Episode Schizophrenia . . . . . ...
متن کاملChallenges in the search for drugs to treat central nervous system disorders.
The history of drug discovery spans approximately 200,000 years. For much of this time, the identification of therapeutic agents was empirical, with the shift to a more hypothesis-driven approach occurring in the late 19th century. Since then, the objective has changed from identifying an active drug and its mechanism of action to determining therapeutic potential only after identifying drug-li...
متن کاملPharmacological fMRI and EEG for the development of novel analgesic compounds
Functional magnetic resonance imaging (fMRI) and electroencephalography (EEG) have been introduced in pharmacological studies with the aim to measure the modulation of brain activity by drugs acting directly on the central nervous system (CNS) or indirectly on its afferent input. By providing novel and specific biomarkers which could substitute or complement clinical endpoints, this approach is...
متن کامل